A population of circulating mononuclear cells from patients with AIDS was identified which expressed interleukin 2 re-
Introduction
The central role of monocyte/macrophages in immunologic events suggests that these cells may play an important role in the pathogenesis of the acquired immunodeficiency syndrome (AIDS). The human immunodeficiency virus (HIV) infects CD4 positive lymphocytes (1) (2) (3) as well as cells of monocyte/ macrophage lineage, including peripheral blood monocytes (4) (5) (6) (7) (8) and tissue macrophages (9) (10) (11) (12) (13) (14) (15) that also express CD4 receptors. Monocytes obtained from patients with AIDS ex-hibit phenotypic and functional abnormalities (16) , some of which are consistent with an activated state of the circulating monocytes (17) . In this regard, monocytes from AIDS patients may express altered levels of surface HLA-DR (18, 19) and chemotactic ligand receptors (8, 20) , and increased levels of IL-1 (21) (22) (23) .
Monocyte dysfunction also has been associated with impaired T cell proliferative responses in AIDS patients (24, 25) . Two critical requirements for T cell proliferation, the secretion of interleukin 2 (IL-2) and the expression of surface IL-2 receptors (IL-2R)' on T cells, are impaired in AIDS patients (26) (27) (28) . The decreased IL-2 could be due to reduced production or to increased depletion. -Soluble IL-2R which can bind IL-2 (29) have been identified in sera from HIV-seropositive persons (30) (31) (32) (33) , providing a mechanism for IL-2 depletion. Additionally, the diminished levels of IL-2 detected in AIDS patients could be the consequence of IL-2 binding and/or metabolism by monocytes, since activated monocytes express functional IL-2R (34) (35) (36) . Although the increased levels of soluble IL-2R are commonly presumed to be the consequence of shedding by activated CD4 positive lymphocytes (37) , activated monocytes may also release IL-2R into the serum. In the present study, we demonstrate for the first time that peripheral blood monocytes from patients with AIDS express significant levels of IL-2R, that this may be an important mechanism for IL-2 depletion, and furthermore, that HIV can directly induce IL-2R expression on monocytes in vitro.
Methods
Patients. The study included 22 homosexual males with AIDS. Of these patients, 1 was asymptomatic, 7 had Kaposi's sarcoma, and 14 had one or more opportunistic infections. None of the patients had known bacterial infections. No patient was on immunomodulatory or antiviral therapy at the time of study. Control subjects were 22 healthy seronegative heterosexual adults.
Mononuclear leukocyte suspensions. Mononuclear leukocytes (MNL) isolated from heparinized peripheral blood of patients and control subjects by Ficoll-Paque sedimentation were washed and suspended in Dulbecco's modified Eagle's medium (DME, Gibco Laboratories, Grand Island, NY) containing 50 ,g/ml gentamicin and 2 mM glutamine. Total MNL, monocyte, and lymphocyte numbers were determined by Coulter Counter size analysis (Coulter Electronics Inc., Hialeah, FL) and phenotypic staining (see below). To obtain highly purified populations of monocytes and lymphocytes, MNL from leukapheresis preparations of healthy control subjects (National Institutes of Health Blood Bank) were separated by counterflow centrifugal elutriation (CCE) (38 In vitro infection with HIV-J. CCE-purified normal monocytes (> 95% Leu M3+) were suspended (10 X 106) in I ml of supernatant containing HIV-I/HTLV-IIIB,-L (5 X 105 cpm reverse transcriptase), an isolate derived from alveolar macrophages of a patient with AIDS (6), as previously described (8) . Control monocytes were suspended in RPMI 1640 (Gibco Laboratories) containing 20% FCS, and/or in supernatant without virus for I h with intermittent shaking at 37°C. The cells were washed and resuspended in RPMI 1640 containing 10% FCS, antibiotics, and glutamine. After incubation in suspension at 37°C for varying intervals, the monocytes were analyzed for surface antigen expression. Viral infection was confirmed by determining p24 and reverse transcriptase levels and by ultrastructural evaluation of parallel adherent monocyte cultures as previously described (8) .
Treatment ofmonocytes with gpJ20 and anti-CD4a. In additional studies, CCE-purified normal monocytes were cultured in suspension with purified HIV-1 envelope glycoprotein gpl2O or the core protein p24. The gpl20 was isolated from the culture fluids or cell membrane extracts of HIV-I/HTLV-IIIB or HIV-I/HTLV-IIIpF infected H9 cells by immunoaffinity chromatography (41) and the core protein p24 was purified as described (42) . For some assays, the gpl20 was immunoprecipitated with goat anti-gpl2O sera (8) . At the highest concentrations tested these preparations had < 0.2 ng/ml of endotoxin as determined by the 
Results
Identification ofIL-2R' monocytes in AIDS patients. In order to differentiate IL-2R+ monocytes from other circulating cells which might be expressing IL-2R, the MNL were simultaneously stained with FITC-IL-2R (green) and PE-Leu M3 (red). As shown by dual fluorescence FMF, very few (< 1%) Leu M3', IL-2R' cells were present in the MNL from a representative normal subject ( Fig. 1 A, (Fig. 1 B) . In addition to analysis of freshly isolated monocytes from patients and control subjects for IL-2R expression, monocytes were examined for inducible IL-2R expression (35) . In these experiments, aliquots of MNL were incubated for 24 h in the presence or absence of LPS (10 gg/ml) before phenotypic analysis. Monocytes from control subjects cultured in DME only for 24 h did not express IL-2R. However, Leu M3' monocytes from all of the control subjects were induced to express significant levels of IL-2R by LPS treatment (2.0±0.4% before vs. 62.5±5.2% after LPS; P < 0.001) ( Fig. 1 B, (Fig. 2, C) . However, the presence of steady-state levels of IL-2R mRNA in the adherent monocytes from the AIDS patients without in vitro activation (Fig. 2 , Al, A2, A3) indicated that these populations of IL-2R+ cells had been previously activated. Further stimulation of these cells with LPS in vitro minimally augmented the already elevated levels of IL-2R mRNA (Fig. 2) . Interestingly, unstimulated monocytes from patient Al appeared to selectively express the 1.5-kb transcript with little or no expression of the 3.5-kb species. However, after LPS stimulation, both RNA species were expressed in equal proportions. Previous studies indicate that both RNA species encode the functional IL-2R molecule (39 Fig. 4 , the monocytes cultured in medium only or sham-infected with virus-free macrophage supernatants were IL-2R negative (< 5%) at each time point throughout the 6 d of culture. In contrast, > 25% of the cells exposed to HIV-l became IL-2R' by day 2 with > 60% of the monocytes expressing IL-2R within 6 d after infection. Fluorescence profiles of these populations (Fig. 4 , right panels) illustrate the prominent shift in To confirm viral infection, cultures were evaluated for p24 levels. Although p24 levels could not be detected in the suspension cultures during the 6 d of evaluation, long-term cultures ofthese infected cells maintained under adherence conditions, also negative for p24 at day 6, began to exhibit p24 levels 7 d after infection (0.1-0.4 ng/ml) with higher levels by day 14 (2 5 ng/ml). Thus, as previously demonstrated (8) , evidence of infection by these parameters could not be documented until > 7 d after inoculation of the monocytes with HIV-1. By day 10, as many as 50% of the monocyte/macrophages in some sections contained intracellular viral particles by ultrastructural analysis. Thus, the phenotypic changes following initial in vitro exposure to HIV-I appeared to mimic those identified on monocytes from patients with AIDS, including increased HLA-DR expression and synthesis of IL-2 cell surface receptors, but without evidence of productive infection. Pathway of signal transduction leading to IL-2R expression. In recent studies, we demonstrated that the HIV-1 envelope glycoprotein gpl20 as well as antibodies to CD4, both of which bind to the CD4 receptor, stimulate certain monocyte functions (8, 43) . To determine whether gpl20 could effectively induce IL-2R expression on normal monocytes in parallel with augmented HLA-DR, gpl20 at the previously deter-mined optimal dose of 200-300 ng/ml was added to CCEenriched monocyte populations. Conservation of the binding region of gpl20 in different isolates (44) and previous studies demonstrating monocyte CD4 modulation after gp 120 treatment (8, 43) , suggest that the gpl20 from HIV-l/HTLV-IIIB and/or HIV-I/HTLV-IIIRF are appropriate ligands for monocyte CD4 interactions. The gpl20 induced monocyte differentiation as determined by increased HLA-DR (RPMI 122 for gpl20-treated monocytes vs. RMFI 109 for controls) and increased surface IL-2R expression (61% vs. 4%) (Fig. 5, top  panels) . Furthermore, the kinetics of IL-2R expression induced by gp120 were similar to those for HIV-1-induced IL-2R in that at least 24 h were required to enable adequate transcription and translation for detection of cell surface receptor expression. The gp 120-dependent stimulation of monocytes was blocked by treatment with an antibody to gpl20 (Table II) and did not occur in response to another viral product, the core protein p24 (Table II) .
Since gpl 20 binds to the CD4 receptor, antibodies that bind to the same epitope should mimic the signal transduced by this ligand-receptor interaction. We tested this possibility by evaluating monocytes incubated with antibodies to CD4 for changes in IL-2R and HLA-DR expression. As shown in Fig. 5 (lower panels), both IL-2R expression (42% after anti-CD4; 4% for control) and HLA-DR levels (RMFI 125 after anti-CD4; RMFI 109 for control) were augmented 24 h after treatment with 1-3 ,g/ml anti-CD4a (24, 25) . Thirdly, monocyte shedding of IL-2R may contribute to the increased levels of soluble serum IL-2R in AIDS patients (30) (31) (32) (33) . Finally, modulation of IL-2R+ monocytes by IL-2 may further influence the abnormalities of monocyte function associated with this disease (16) .
The ability of HIV-1 to bind to monocytes through their CD4 receptors and to induce the expression of cellular genes, particularly thQse encoding differentiation markers such as IL-2R and HLA-DR, likely contributes to the immunopathogenesis of AIDS. Our in vitro observations are consistent with the increased expression of activation markers present on circulating monocytes in some AIDS patients (8, 16, 18) . Furthermore, these data provide a rational basis for the paradox of a cell population which is phenotypically differentiated, but functionally impaired (8, 25, (45) (46) (47) . Monocytes infected with
IL-2R
Fluorescence Intensity Figure 5 . Modulation of HLA-DR and IL-2R by gpl20 and antiCD4a. CCE-purified monocytes were incubated with medium only (control), 300 ng/ml gpl20 ( 21, 48) , which promote fever and other metabolic effects. However, as the responsive T cell population is depleted, these monocyte products may become ineffective in promoting host defense.
The AIDS virus may infect cells of the monocyte/macrophage lineage before infection of T lymphocytes (49) . Our observations offer, in part, a mechanism for enhancement of monocyte-T cell interactions and consequently, the possible transfer of virus from monocytes to CD4+ lymphocytes. First, increased HLA-DR expression on monocytes after exposure to HIV-1 would promote monocyte-CD4+ T cell interactions since helper/inducer T cells recognize antigens in association with MHC class II HLA determinants (50) . Secondly, spontaneous release of IL-1 by the HIV-1-infected monocytes (21) would also promote T cell proliferation and consequently replication of the virus in the T cells (49) . Increased expression and/or release of virus and gp 120 could then infect or activate additional monocytes. This cycle of monocyte-T lymphocyte interaction may persist with continued T cell infection and depletion. Furthermore, as the monocyte/macrophages become productively infected by HIV-1, they may become functionally deficient (McCartney-Francis, N., personal communication) with decreased HLA-DR expression as has been observed in some patient studies ( 19) .
In summary, our study provides evidence in support of the recently proffered hypothesis (51, 52 ) that infection of monocytes by HIV-1 leads initially to activation and/or overstimulation of the immune system. Activation of CD4', HIV-1 + T cells ultimately results in destruction of this population and immunosuppression. Based on this concept, attempts to selectively kill the infected cells in conjunction with antiviral therapy which inhibits HIV-l in monocytes (53, 54) as well as in T cells, offers a rational approach for therapeutic modulation of the immune system in the acquired immunodeficiency syndrome.
